Amgen’s stock faced pressure in 2024 due to disappointing Phase 2 results for its weight-loss drug, MariTide, despite strong earnings reports. Meanwhile, Chevron and Verizon navigated challenging market conditions, with Chevron’s performance buoyed by dividends and Verizon’s growth hindered by significant debt. Johnson & Johnson and Merck also struggled, facing headwinds from market dynamics and regulatory challenges.
about Investment Insights on Dogs of the Dow for 2025Cisco Systems Inc.
0 in Finance and 0 in Crypto last weekChainlink’s Role as the Backbone of Web3 and Blockchain Infrastructure
Chainlink is emerging as a critical infrastructure provider for blockchain, akin to Cisco’s role in the early internet. Its decentralized oracle network connects smart contracts to off-chain data, essential for scaling decentralized applications like Aave and Uniswap. Despite being undervalued, analysts predict significant growth for Chainlink as blockchain adoption increases, with its native token LINK currently priced at $22.80 and expected to rise to $30 amid growing demand and whale activity.
about Chainlink's Role as the Backbone of Web3 and Blockchain Infrastructure